Silva Deželan

Head of Impact & ESG at Forbion

Speaker

Dr. Silva Dezelan is Forbion’s Head of Impact & ESG, responsible for its impact and ESG initiatives, strategy and further implementation. Prior to joining Forbion, Silva worked as ESG Director at Stafford Capital Partners, private markets and reals assets specialist. Before Stafford, Silva was responsible for ESG integration and the implementation of ESG engagement across different private equity programs of Robeco.

Before her position at Robeco, Silva oversaw the Responsible Investing Program at Rabobank Sustainability Directorate and held a position of a fund analyst at Rabobank Private Banking. She started her career in responsible investing as an SRI analyst at the Institute for Investment Services Research in 2007. Prior to that, Silva was an Assistant Professor of Finance at the Faculty of Economics of the University of Ljubljana in Slovenia.

Silva is the vice-chair of Invest Europe’s ESG Committee and a member of the NVP’s Responsible Investment Committee. She holds a PhD in Economics from the University of Amsterdam, the Netherlands, and a Master’s degree in Finance from the University of Ljubljana, Slovenia.

*****

Forbion (www.forbion.com) is a dedicated life sciences venture capital firm with offices in The Netherlands, Germany and Singapore. Forbion invests in life sciences companies that are active in the (bio-) pharmaceutical space. Forbion manages well over €2.3 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. Forbion’s current team consists of over 30 life sciences investment professionals that have built an impressive performance track record since the late nineties with successful investments in 95 companies. The firm is a signatory to the United Nations Principles for Responsible Investment. Besides financial objectives, Forbion selects investments that will positively affect the health and well-being of patients. Forbion operates a joint venture with BioGeneration Ventures (BGV), the manager of seed and early-stage funds.